You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
先声药业(02096.HK)与阿尔脉生物达成创新药研发战略合作
阿思达克 12-15 17:08
先声药业(02096.HK)宣布,与阿尔脉生物科技签订新药发现战略合作协议,双方将利用人工智能技术和DNA编码化合物库设计、合成和筛选技术,筛选肿瘤、中枢神经、自身免疫等疾病领域的一系列特定靶点的先导化合物,同时基於筛选数据为特定靶点建立机器学习模型,用於虚拟筛选和化合物结构优化。

先声药业董事长任晋生表示,AI赋能药物设计具有极大的潜力,是新兴的颠覆性技术,可以为下一代高度选择性以及不可成药靶点的药物分子发现提供技术支撑,有助於加速发现小分子创新药早期化合物。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account